CompaniesApica Cardiovascular

Apica Cardiovascular

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

1

As Collaborator

4

Total Enrollment

330,111

By Phase

NA: 1PHASE1/PHASE2: 1

By Status

NOT_YET_RECRUITING: 3ENROLLING_BY_INVITATION: 1COMPLETED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT06624267
NCT06628297
NCT06330480
Hover over trial bars to see details

Recent Trials

NCT06413160Collaborator
The Cardiovascular-Renal-Metabolic (CRM) Syndrome Survey in Jordan
N/ANot yet recruiting
10,000 participants
Started: Jul 1, 2025 · Completed: Dec 31, 2026
NCT06330480Collaborator
Check@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney Disease
NAEnrolling by invitation
320,000 participants
Started: May 14, 2025 · Completed: Nov 1, 2028
NCT06624267Collaborator
Test of Reproducibility of [15O]H20-PET Assessment of Brain Perfusion
N/ANot yet recruiting
8 participants
Started: Nov 30, 2024 · Completed: Dec 31, 2027
NCT06628297Collaborator
Comparison of Differencens in VO2-max, Perfusion of the Heart and Brain and Cognitive Performance Between Patients with Type 2 Diabetes and Healthy Age Matched Controls.
N/ANot yet recruiting
72 participants
Started: Nov 30, 2024 · Completed: Dec 31, 2027
NCT01721642Lead Sponsor
A Pilot Study to Evaluate the Safety and Efficacy of the Apica Access, Stabilization and Closure (ASC™) Device
PHASE1/PHASE2Completed
31 participants
Started: May 31, 2012 · Completed: Mar 31, 2013
Related Companies
Thoratec
acquired